Log In
Print this Print this

TC-DC, eltrapuldencel-T (CLBS20, NBS20) (formerly melapuldencel-T)

Also known as: DC-TC, Tumor Stem Cell Specific Dendritic Cell therapy (formerly NBS-20)

  Manage Alerts
Collapse Summary General Information
Company Caladrius Biosciences Inc.
DescriptionAutologous dendritic cells loaded with antigen from self-renewing, proliferating autologous tumor cells in GM-CSF
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Non-stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today